- Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45)
-
Kim JH
- KMID: 2553602
- Diabetes Metab J.
- 2024 Mar;48(2):321-322.
- doi: 10.4093/dmj.2024.0070
-
- CITED
-
- Close
- SHARE
-
- Close
- Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45)
-
Wang SY, Xu L
- KMID: 2553603
- Diabetes Metab J.
- 2024 Mar;48(2):323-324.
- doi: 10.4093/dmj.2024.0085
-
- CITED
-
- Close
- SHARE
-
- Close
- Enhancing Patient Outcomes: Prioritizing SGLT2is and GLP-1RAs in Diabetes with CVD
-
Koh G
- KMID: 2553591
- Diabetes Metab J.
- 2024 Mar;48(2):208-212.
- doi: 10.4093/dmj.2024.0096
-
- CITED
-
- Close
- SHARE
-
- Close
- SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes
-
Jeon JH
- KMID: 2553592
- Diabetes Metab J.
- 2024 Mar;48(2):213-214.
- doi: 10.4093/dmj.2024.0079
-
- CITED
-
- Close
- SHARE
-
- Close
- A New Concept in Antidiabetic Therapeutics: A Concerted Removal of Labile Iron and Intracellular Deposition of Zinc
-
Vinokur V, Berenshtein E, Chevion M, Chevion D
- KMID: 2553604
- Diabetes Metab J.
- 2024 Mar;48(2):325-325.
- doi: 10.4093/dmj.2024.0124
-
- CITED
-
- Close
- SHARE
-
- Close
- Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
-
Deerochanawong C, Kim SG, Chang YC
- KMID: 2553589
- Diabetes Metab J.
- 2024 Mar;48(2):184-195.
- doi: 10.4093/dmj.2023.0168
Hypertriglyceridemia and decreased high-density lipoprotein cholesterol (HDL-C) persist despite statin therapy, contributing to residual atherosclerotic cardiovascular disease (ASCVD) risk. Asian subjects are metabolically more susceptible to hypertriglyceridemia than other ethnicities.... -
- CITED
-
- Close
- SHARE
-
- Close
- One-Carbon Metabolism Nutrients, Genetic Variation, and Diabetes Mellitus
-
Zhu J, Saikia G, Zhang X, Shen X, Kahe K
- KMID: 2553588
- Diabetes Metab J.
- 2024 Mar;48(2):170-183.
- doi: 10.4093/dmj.2023.0272
Diabetes mellitus (DM) affects about 9.3% of the population globally. Hyperhomocysteinemia (HHcy) has been implicated in the pathogenesis of DM, owing to its promotion of oxidative stress, β-cell dysfunction, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study
-
Yang YS, Kim NH, Baek JH, Ko SH, Son JW, Lee SH, Rhee SY, Kim SK, Sohn TS, Jun JE, Jeong IK, Kim CH, Song K, Rhee EJ, Noh J, Hur KY, Committee of Clinical Practice Guidelines, Korean Diabetes Association
- KMID: 2553598
- Diabetes Metab J.
- 2024 Mar;48(2):279-289.
- doi: 10.4093/dmj.2023.0225
Background: Recent diabetes management guidelines recommend that sodium-glucose cotransporter 2 inhibitors (SGLT2is) or glucagon-like peptide 1 receptor agonists (GLP-1RAs) with proven cardiovascular benefits should be prioritized for combination therapy in... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
-
Friedman SL
- KMID: 2553587
- Diabetes Metab J.
- 2024 Mar;48(2):161-169.
- doi: 10.4093/dmj.2023.0240
Metabolic dysfunction-associated steatotic (fatty) liver disease (MASLD), previously termed non-alcoholic fatty liver disease, is a worldwide epidemic that can lead to hepatic inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus
-
Ooi YG, Sarvanandan T, Hee NKY, Lim QH, Paramasivam SS, Ratnasingam J, Vethakkan SR, Lim SK, Lim LL
- KMID: 2553590
- Diabetes Metab J.
- 2024 Mar;48(2):196-207.
- doi: 10.4093/dmj.2023.0244
People with type 2 diabetes mellitus have increased risk of chronic kidney disease and atherosclerotic cardiovascular disease. Improved care delivery and implementation of guideline-directed medical therapy have contributed to the... -
- CITED
-
- Close
- SHARE
-
- Close
- Extracellular Vimentin Alters Energy Metabolism And Induces Adipocyte Hypertrophy
-
Park JH, Kwon S, Park YM
- KMID: 2553593
- Diabetes Metab J.
- 2024 Mar;48(2):215-230.
- doi: 10.4093/dmj.2022.0332
Background: Previous studies have reported that oxidative stress contributes to obesity characterized by adipocyte hypertrophy. However, mechanism has not been studied extensively. In the current study, we evaluated role of... -
- CITED
-
- Close
- SHARE
-
- Close
- Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients
-
Park YH, Sohn M, Lee SY, Lim S
- KMID: 2553596
- Diabetes Metab J.
- 2024 Mar;48(2):253-264.
- doi: 10.4093/dmj.2023.0128
Background: We investigated the long-term efficacy and safety of initial triple therapy using metformin, a dipeptidyl peptidase-4 inhibitor, and a sodium-glucose cotransporter-2 inhibitor, in patients with type 2 diabetes mellitus. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Depression according to Cumulative Exposure to a Low-Household Income Status in Individuals with Type 2 Diabetes Mellitus: A Nationwide Population- Based Study
-
Park SH, Lee YB, Lee Kn, Kim B, Cho SH, Kwon SY, Park J, Kim G, Jin SM, Hur KY, Han K, Kim JH
- KMID: 2553599
- Diabetes Metab J.
- 2024 Mar;48(2):290-301.
- doi: 10.4093/dmj.2022.0299
Background: We aimed to identify the risk of incident depression according to cumulative exposure to a low-household income status in individuals with type 2 diabetes mellitus (T2DM). Methods: For this retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Hyperglycemia on Complication and Mortality after Transarterial Chemoembolization for Hepatocellular Carcinoma
-
Moon SJ, Ahn CH, Lee YB, Cho YM
- KMID: 2553600
- Diabetes Metab J.
- 2024 Mar;48(2):302-311.
- doi: 10.4093/dmj.2022.0255
Background: Current guidelines regarding periprocedural glycemic control to prevent complications after nonsurgical invasive procedures are insufficient. Transarterial chemoembolization (TACE) is a widely used treatment for unresectable hepatocellular carcinoma. We aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis
-
Kim JS, Lee G, Park KI, Oh SW
- KMID: 2553601
- Diabetes Metab J.
- 2024 Mar;48(2):312-320.
- doi: 10.4093/dmj.2022.0421
Background: There is still a lack of research on which diabetic drugs are more effective in preventing stroke. Our network metaanalysis aimed to compare cerebrovascular benefits among glucose-lowering treatments. Methods: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Glucolipotoxicity Suppressed Autophagy and Insulin Contents in Human Islets, and Attenuation of PERK Activity Enhanced Them in an ATG7-Dependent Manner
-
Moon S, Lim JY, Lee M, Han Y, Kim H, Kwon W, Jang JY, Kim MN, Park KS, Jung HS
- KMID: 2553594
- Diabetes Metab J.
- 2024 Mar;48(2):231-241.
- doi: 10.4093/dmj.2022.0366
Background: Administration of pancreatic endoplasmic reticulum kinase inhibitor (PERKi) improved insulin secretion and hyperglycemia in obese diabetic mice. In this study, autophagic balance was studied whether to mediate it. Methods: Human... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Cardiovascular Disease according to Baseline Low-Density Lipoprotein Cholesterol Level in Different Age Groups in Korean Diabetes Population: A Cohort Study
-
Yoo TK, Han KD, Rhee EJ, Lee WY
- KMID: 2553597
- Diabetes Metab J.
- 2024 Mar;48(2):265-278.
- doi: 10.4093/dmj.2022.0443
Background: The association between low-density lipoprotein (LDL-C) levels and cardiovascular disease (CVD) risk in different age groups within the diabetes mellitus (DM) population remains unclear. The cohort study was conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis
-
Chuang MH, Tang YS, Chen JY, Pan HC, Liao HW, Chu WK, Cheng CY, Wu VC, Heung M
- KMID: 2553595
- Diabetes Metab J.
- 2024 Mar;48(2):242-252.
- doi: 10.4093/dmj.2023.0201
Background: The initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2i) typically leads to a reversible initial dip in estimated glomerular filtration rate (eGFR). The implications of this phenomenon on clinical outcomes are... -
- CITED
-
- Close
- SHARE
-
- Close
